Neurologic Solutions Granted FDA 510K Clearance for its Seizure Onset Zone Detection Software
BALTIMORE, Md. (April 1, 2021)—Neurologic Solutions, Inc. announced today that it received 510K clearance from the U.S. Food and Drug
BALTIMORE, Md. (April 1, 2021)—Neurologic Solutions, Inc. announced today that it received 510K clearance from the U.S. Food and Drug
BALTIMORE, Md. (May 13th, 2021)—Neurologic Solutions, Inc. announced today that it received the National Science Foundation SBIR Phase I grant